In summary, post-ischemic modification of the LRP1 and RAGE genes is useful in the study of the ischemic pathways and molecular factors involved in the development of Alzheimer’s disease. This evidence concerns the gene LRP1 and early-onset autosomal dominant Alzheimer disease.